CH616413A5 - Process for the preparation of 2,4-diamino -5-(3',4',5'-trimethoxybenzyl)pyrimidine intended as a potentiator for sulphacetamide contained in pharmaceutical preparations in addition to polymixin - Google Patents

Process for the preparation of 2,4-diamino -5-(3',4',5'-trimethoxybenzyl)pyrimidine intended as a potentiator for sulphacetamide contained in pharmaceutical preparations in addition to polymixin Download PDF

Info

Publication number
CH616413A5
CH616413A5 CH1737374A CH1737374A CH616413A5 CH 616413 A5 CH616413 A5 CH 616413A5 CH 1737374 A CH1737374 A CH 1737374A CH 1737374 A CH1737374 A CH 1737374A CH 616413 A5 CH616413 A5 CH 616413A5
Authority
CH
Switzerland
Prior art keywords
polymixin
preparation
trimethoxybenzyl
diamino
pyrimidine
Prior art date
Application number
CH1737374A
Other languages
German (de)
English (en)
Inventor
Elvin Albert Holstius
George E Alvan
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of CH616413A5 publication Critical patent/CH616413A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH1737374A 1973-12-27 1974-12-30 Process for the preparation of 2,4-diamino -5-(3',4',5'-trimethoxybenzyl)pyrimidine intended as a potentiator for sulphacetamide contained in pharmaceutical preparations in addition to polymixin CH616413A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42891873A 1973-12-27 1973-12-27

Publications (1)

Publication Number Publication Date
CH616413A5 true CH616413A5 (en) 1980-03-31

Family

ID=23700962

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1737374A CH616413A5 (en) 1973-12-27 1974-12-30 Process for the preparation of 2,4-diamino -5-(3',4',5'-trimethoxybenzyl)pyrimidine intended as a potentiator for sulphacetamide contained in pharmaceutical preparations in addition to polymixin

Country Status (22)

Country Link
JP (1) JPS5830284B2 (ja)
AT (1) AT345448B (ja)
BE (1) BE823952A (ja)
CA (1) CA1031263A (ja)
CH (1) CH616413A5 (ja)
CY (1) CY1103A (ja)
DE (1) DE2461570C3 (ja)
DK (1) DK684474A (ja)
ES (1) ES433357A1 (ja)
FI (1) FI374974A (ja)
FR (1) FR2255909B1 (ja)
GB (1) GB1484329A (ja)
HK (1) HK3081A (ja)
IE (1) IE40344B1 (ja)
IL (1) IL46353A (ja)
IN (1) IN140139B (ja)
KE (1) KE3103A (ja)
MC (1) MC1044A1 (ja)
MY (1) MY8400041A (ja)
NL (1) NL7416636A (ja)
SE (1) SE421996B (ja)
ZA (1) ZA748179B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL62447A (en) * 1980-03-21 1983-11-30 Wellcome Found Stabilized ophthalmic formulations
ES2079994B1 (es) * 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
ES2913058T3 (es) 2016-08-16 2022-05-31 Univ Rochester Composición farmacéutica que contiene terapéutico a base de polimixina b/trimetoprima

Also Published As

Publication number Publication date
DE2461570A1 (de) 1975-07-10
FR2255909A1 (ja) 1975-07-25
AU7696174A (en) 1976-07-01
CA1031263A (en) 1978-05-16
CY1103A (en) 1981-09-11
GB1484329A (en) 1977-09-01
JPS5830284B2 (ja) 1983-06-28
ZA748179B (en) 1976-07-28
IE40344L (en) 1975-06-27
ATA1034074A (de) 1978-01-15
FR2255909B1 (ja) 1978-06-30
SE7416310L (sv) 1975-06-30
SE421996B (sv) 1982-02-15
MY8400041A (en) 1984-12-31
DE2461570B2 (de) 1981-06-04
JPS5095418A (ja) 1975-07-29
IE40344B1 (en) 1979-05-09
IN140139B (ja) 1976-09-18
KE3103A (en) 1981-02-13
BE823952A (fr) 1975-06-27
MC1044A1 (fr) 1975-10-10
DK684474A (ja) 1975-09-08
IL46353A0 (en) 1975-04-25
HK3081A (en) 1981-01-30
AT345448B (de) 1978-09-11
DE2461570C3 (de) 1982-05-19
NL7416636A (nl) 1975-07-01
IL46353A (en) 1977-12-30
ES433357A1 (es) 1977-04-01
FI374974A (ja) 1975-06-29

Similar Documents

Publication Publication Date Title
DE3872029T2 (de) Rektal absorbierbare form von l-dopa.
DE3607381A1 (de) Verwendung von diphenylhydantoin und seinen derivaten zur behandlung von immunerkrankungen
EP0761650B1 (de) Thermostabile und lagerfähige Kristallmodifikation von N-Methyl-N-((1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)-ethyl)-2,2-diphenyl-acetamid und Verfahren zu dessen Herstellung
DE1908991C3 (ja)
CH676549A5 (ja)
DE3035688C2 (ja)
CH616413A5 (en) Process for the preparation of 2,4-diamino -5-(3',4',5'-trimethoxybenzyl)pyrimidine intended as a potentiator for sulphacetamide contained in pharmaceutical preparations in addition to polymixin
DE2123318C2 (de) 4-Butylamino-1-äthyl-1H-pyrazolo[3,4-b]pyridin-5-carbonsäureäthylester, Verfahren zu dessen Herstellung und diesen enthaltende pharmazeutische Mittel
DE2355262B2 (de) 1-Piperidinsulfonylharnstoffe, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE3785953T2 (de) Bakterientötende Gemische.
DE1900772A1 (de) Dimethylbiguanidderivat
DE2612545A1 (de) 3-(2,5-dihydroxyphenyl)-alanin als herzstimulans
DE2549417A1 (de) Neue benzolderivate
DE2055853C3 (de) Procain-Phenylbutazon, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen
EP1434761B1 (de) Salze von guanidinderivaten und pharmazeutische zubereitungen daraus
DE3706431C2 (ja)
DE4419973A1 (de) Monohydratform des (R)-2-Cycloheptylmethylaminomethyl-8-methoxy-chroman-hydrochlorids
DE1939139C3 (de) n-Decylester der 4-Aminobuttersäure und hautverträgliches antiseptisches Mittel, enthaltend einen n-Alkylester der 4-Aminobuttersäure
DE1593970C3 (de) Homoargininpolymere und Verfahren zu ihrer Herstellung
DE2227842C3 (de) Diphenylcyclopentane und diese enthaltende Arzneimittel
DE3634989C2 (de) Verfahren zur Herstellung von substituierten Bisphenolen
AT318807B (de) Verfahren zur Herstellung eines neuen Salzes eines Penicillinesters
DE1768878C (de) Tetracyclylmethyl p methvlamino benzoesäure, deren pharmakologisch vertraglichen Salze mit Basen oder Sauren und diese enthaltende thera peutische Mischungen
DE10341233A1 (de) Kombination von Phenylcarbonsäureamiden mit beta-Adrenozeptoren-Blockern und deren Verwendung zur Behandlung von Vorhofarrhythmien
AT234114B (de) Verfahren zur Herstellung von neuen Benzolsulfonylharnstoffen

Legal Events

Date Code Title Description
PL Patent ceased